提升我国医药企业社会责任路径研究
x

请在关注微信后,向客服人员索取文件

篇名: 提升我国医药企业社会责任路径研究
TITLE:
摘要: 目的:为加强我国医药企业社会责任的监督和管理提供参考。方法:分析我国医药企业社会责任现状及美国、欧洲国家等的国际经验,提出我国医药企业社会责任提升路径。结果与结论:从2005年企业社会责任首次写入《中华人民共和国公司法》后,我国政府日益重视企业社会责任的落实,但我国医药企业社会责任尚处于起步阶段并落后于其他行业。美国通过制定完善的医药政策法规、非政府组织参与监管、建立完善的金融激励机制等多路径提升企业的社会责任;德国、英国等欧洲国家的政府部门在推动企业社会责任中扮演着重要的角色,同时,完善的公民社会的监督体系是企业社会责任的重要推动力。我国在提升医药企业社会责任时,应通过充分发挥政府的监督管理作用、加强社会公众的监督和管理作用、加强社会金融责任制度建设、提高医药企业责任意识等多路径,切实提高医药企业的社会责任意识。
ABSTRACT: OBJECTIVE: To provide reference for strengthening the supervision and management of responsibility of pharmaceutical corporates in China. METHODS: The status quo of social responsibility of pharmaceutical corporates in China were an- alyzed, and international experience of the United States, European countries and so on were analyzed. The ways to enhance the social responsibility of pharmaceutical corporates in China were proposed. RESULTS & CONCLUSIONS: Since the corporate social responsibility was first written into the People’s Republic of China Company Law in 2005, the Chinese government has attached great importance to the implement of corporate social responsibility; however, the social responsibility of pharmaceutical corporates in China is still in the initial stage and lags behind other industries. The United States promotes corporate social responsibility through the formulation of perfect medical policies and regulations, non-governmental organizations participating in supervision, and the establishment of a sound financial incentive mechanism; Government in Germany, Britain and other European countries play an important role in promoting corporate social responsibility; at the same time, perfect supervision system of civil society is an important driving force to promote corporate social responsibility. When promoting the social responsibility of pharmaceutical co- rporates in China, it is necessary to improve the awareness of social responsibility of pharmaceutical enterprises through multiple paths, such as giving full play the supervision and management role of government, strengthening public supervision and management function, strengthening the system construction of social financial responsibility, improving the awareness of responsibility of pharmaceutical corporates.
期刊: 2018年第29卷第1期
作者: 沈茜
AUTHORS: SHEN Xi
关键字: 医药企业;社会责任;提升路径;国际经验
KEYWORDS: Pharmaceutical corporate; Social responsibility; Promoting path; International experience
阅读数: 159 次
本月下载数: 74 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!